[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

NCT04727632 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped It was not feasible to perform FES PET/CT

Conditions

Estrogen Receptor Positive Breast Cancer

Interventions

DRUG: [18F]Fluoroestradiol (FES) PET/CT

Sponsor

University of Utah